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limitations in our knowledge. Additional basic
and operational research was strongly urged.
Some participants expressed concern over the
use of the term “elimination,” on the grounds that
the distinctions between elimination and control
and elimination and eradication were unclear.
Further discussion and possible revision of these
terms were recommended.
In summary, the conference provided a
multidisciplinary forum for addressing issues
around elimination and eradication and their
relationship to sustainable health development.
There was widespread agreement that an
eradication program could have many positive
effects on systems development and that explicit
efforts should be made to maximize these positive
effects as well as to minimize any negative
effects. Community mobilization and organiza-
tion should be seen as a component of sustainable
health development, with the additional poten-
tial for disease control and eradication. The
conclusions and recommendations of the confer-
ence should be brought to other forums  to expand
international health goals and strengthen the
mutual ties between sustainable health develop-
ment and disease control, elimination, and
eradication.
For further information, contact Dr. Walter R.
Dowdle, 404-371-0466, e-mail: wdowdle@taskforce.org;
or Dr. Richard Goodman, 404-639-7400, e-mail:
rag4@cdc.gov.
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In the article, “Emerging Infectious Diseases—
Brazil,” by Hooman Momen, on page 3 the last sentence
of the next-to-the-last paragraph should read, “The
existing, generally passive epidemiologic surveillance
system produces information that arrives too late to be
effective; however, a number of measures, if
implemented immediately, can mitigate the impact of
any future epidemic: a containment laboratory
(biosafety level 4) that can handle known and unknown
microbes of high virulence; at least one infirmary,
properly designed and fully equipped, to treat highly
contagious and virulent diseases (the current lack of
this facility poses a great danger to the population
should an outbreak of such a disease occur); and a
mobile multidisciplinary task force, including epidemi-
ologists, microbiologists, entomologists, and clinicians,
ready to investigate suspected disease outbreaks on
short notice.”
New and Reemerging Infectious
Diseases: A Clinical Course
Atlanta, Georgia, USA, June 13-15, 1998
Jointly sponsored by the Emory
University School of Medicine, Centers for
Disease Control and Prevention, and
National Foundation for Infectious Dis-
eases, New and Reemerging Infectious
Diseases: A Clinical Course focuses on the
epidemiology, recognition, treatment, and
management of new and reemerging
infectious diseases. The course will bring
together the foremost infectious disease
clinicians and epidemiologists to present
pertinent information on emerging infec-
tions and prospective therapeutic agents.
For more information, contact Kip
Kantelo at NFID, 4733 Bethesda Avenue,
Suite 750, Bethesda, MD 20814-5228, USA,
tel: 301-656-0003, fax: 301-907-0878, http://
www.nfid.org/nfid, e-mail: kkantelo@aol.com.